Verastem's CEO Talks DYNAMO Study, The Competitive Landscape And Pitch To Investors
January 19, 2017 at 12:29 PM EST
Verastem Inc (NASDAQ: VSTM) is a biopharmaceutical company that focuses on discovering and developing therapies for the treatment of ...